Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Publication year range
1.
Food Sci Nutr ; 11(7): 4233-4245, 2023 Jul.
Article in English | MEDLINE | ID: mdl-37457170

ABSTRACT

The hard-shelled mussel (Mytilus coruscus) has been used as a traditional Chinese medicine and health food in China for centuries. Polysaccharides from mussel has been reported to have multiple biological functions, however, it remains unclear whether mussel polysaccharide (MP) exerts protective effects in intestinal functions, and the underlying mechanisms of action remain unclear. The aim of this study was to investigate the protective effects and mechanism of MP on intestinal oxidative injury in mice. In this study, 40 male BALB/C mice were used, with 30 utilized to produce an animal model of intestinal oxidative injury with intraperitoneal injection of cyclophosphamide (Cy) for four consecutive days. The protective effects of two different doses of MP (300 and 600 mg/kg) were assessed by investigating the change in body weight, visceral index, and observing colon histomorphology. Moreover, the underlying molecular mechanisms were investigated by measuring the antioxidant enzymes and related signaling molecules through ELISA, real-time PCR, and western blot methods. The results showed that MP pretreatment effectively protected the intestinal from Cy-induced injury: improved the colon tissue morphology and villus structure, increased superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px) activities, and reduced malondialdehyde (MDA) content in serum and colon tissues. Meanwhile, MP also significantly increased the expression levels of SOD, GSH-Px, heme oxygenase-1 (HO-1), and nuclear factor E2-related factor 2 (Nrf2) mRNA in colon tissues. Further, western blot results showed that the expression of Nrf2 protein was significantly upregulated while kelch-like ECH-associated protein 1 (Keap1) was significantly downregulated by MP in the colonic tissues. This study indicates that MP can ameliorate Cy-induced oxidative stress injury in mice, and Nrf2-Keap1 signaling pathway may mediate these protective effects.

2.
Waste Manag ; 153: 167-177, 2022 Nov.
Article in English | MEDLINE | ID: mdl-36099727

ABSTRACT

Flotation is an attractive method for separating the different components of waste printed circuit boards (WPCBs) due to its cleanliness and efficiency. Non-metallic particles (NMPs) with good floatability usually need to be floated, however, it is difficult to achieve complete removal. The effect of particle size on the flotation behavior of NMPs, which is usually ignored in previous studies, is concerned in this paper. Flotation tests and kinetic analysis were carried out to reveal the effect of reagent dosage on flotation characteristics of particles in narrow size fractions. As the fineness decreases, the particles are more likely to be floated. Equally, the finer the particle size, the lower the reagent dosage required to achieve the maximum recovery. For 1-0.5 mm and -0.045 mm, the maximum recovery increased from 42.16% (1500 g/t MIBC) to 97.31% (100 g/t MIBC). Therefore, the feasibility of reducing particle size by grinding to improve floatability was verified. The results show that the reduction of particle size can significantly promote its efficiency of being floated. After grinding treatment, -0.045 mm yields in each size fraction (1-0.5, 0.5-0.25, 0.25-0.125, 0.125-0.074, 0.074-0.045 mm) increased by 22.10%, 28.42%, 30.90%, 64.56%, 89.32%, resulting in an increase of 37.71%, 13.12%, 2.82%, 7.82% and 2.00% in maximum recovery, respectively. It is also proved that the particle size, rather than the resin content, has a more significant effect on the floatability of NMPs.


Subject(s)
Electronic Waste , Electronic Waste/analysis , Kinetics , Metals , Particle Size , Recycling
3.
J Microbiol ; 58(8): 716-723, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32524342

ABSTRACT

Human cytomegalovirus (hCMV) is a ubiquitous herpesvirus, which results in the establishment of a latent infection that persists throughout the life of the host and can be reactivated when the immunity is low. Currently, there is no vaccine for hCMV infection, and the licensed antiviral drugs mainly target the viral enzymes and have obvious adverse reactions. Thus, it is important to search for compounds with anti-hCMV properties. The present study aimed to investigate the suppressive effects of piceatannol on hCMV Towne strain infection and the putative underlying mechanisms using human diploid fibroblast WI-38 cells. Piceatannol supplementation prevented the lytic changes induced by hCMV infection in WI-38 cells. Furthermore, piceatannol suppressed the expression of hCMV immediate-early (IE) and early (E) proteins as well as the replication of hCMV DNA in a dose-dependent manner. Moreover, hCMV-induced cellular senescence was suppressed by piceatannol, as shown by a decline in the senescence-associated ß-galactosidase (SA-ß-Gal) activity and decreased production of intracellular reactive oxygen species (ROS). p16INK4a, a major senescence-associated molecule, was dramatically elevated by current hCMV infection that was attenuated by pre-incubation with piceatannol in a dose-dependent manner. These results demonstrated that piceatannol suppressed the hCMV infection via inhibition of the activation of p16INK4a and cellular senescence induced by hCMV. Together, these findings indicate piceatannol as a novel and potent anti-hCMV agent with the potential to be developed as an effective treatment for chronic hCMV infection.


Subject(s)
Antiviral Agents/pharmacology , Cytomegalovirus Infections/drug therapy , Cytomegalovirus/drug effects , Stilbenes/pharmacology , Cell Line , Cellular Senescence/drug effects , Cyclin-Dependent Kinase Inhibitor p16/metabolism , Cytomegalovirus/genetics , Cytomegalovirus/growth & development , Drug Repositioning , Humans , Immediate-Early Proteins/biosynthesis , Reactive Oxygen Species/metabolism , Virus Replication/drug effects , beta-Galactosidase/metabolism
4.
Oxid Med Cell Longev ; 2019: 5276096, 2019.
Article in English | MEDLINE | ID: mdl-31612074

ABSTRACT

Calorie restriction (CR) is a nongenetic intervention with a robust effect on delaying aging in mammals and other organisms. A mild stimulation on mitochondrial biogenesis induced by CR seems to be an important action mode for its benefits. Here, we reported that a component isolated from Rhodiola rosea L., salidroside, delays replicative senescence in human fibroblasts, which is related to its stimulation on mitochondrial biogenesis by activating SIRT1 partly resulted from inhibition on miR-22. Salidroside increased the mitochondrial mass that accompanied an increment of the key regulators of mitochondrial biogenesis including PGC-1α, NRF-1, and TFAM and reversed the mitochondrial dysfunction in presenescent 50PD cells, showing a comparable effect to that of resveratrol. SIRT1 is involved in the inducement of mitochondrial biogenesis by salidroside. The declined expression of SIRT1 in 50PD cells compared with the young 30PD cells was prevented upon salidroside treatment. In addition, pretreatment of EX-527, a selective SIRT1 inhibitor, could block the increased mitochondrial mass and decreased ROS production induced by salidroside in 50PD cells, resulting in an accelerated cellular senescence. We further found that salidroside reversed the elevated miR-22 expression in presenescent cells according to a miRNA array analysis and a subsequent qPCR validation. Enforced miR-22 expression by using a Pre-miR-22 lentiviral construct induced the young fibroblasts (30PD) into a senescence state, accompanied with increased senescence-related molecules including p53, p21, p16, and decreased SIRT1 expression, a known target of miR-22. However, salidroside could partly impede the senescence progression induced by lenti-Pre-miR-22. Taken together, our data suggest that salidroside delays replicative senescence by stimulating mitochondrial biogenesis partly through a miR22/SIRT1 pathway, which enriches our current knowledge of a salidroside-mediated postpone senility effect and provides a new perspective on the antidecrepitude function of this naturally occurring compound in animals and humans.


Subject(s)
Cellular Senescence/drug effects , Glucosides/therapeutic use , MicroRNAs/metabolism , Mitochondria/metabolism , Phenols/therapeutic use , Rhodiola/chemistry , Glucosides/pharmacology , Humans , Organelle Biogenesis , Phenols/pharmacology
6.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-254986

ABSTRACT

<p><b>OBJECTIVE</b>To explore the mechanisms of acupuncture treatment promoting the motor function recovery of neonate rats with cerebral palsy.</p><p><b>METHODS</b>The improved hypoxic-ischemic encephalopathy (HIE) means was performed to establish the model of neonate rats with cerebral palsy. All neonate rats were randomly divided into 3 groups: sham group, model group and acupuncture group (n = 20). We observed and scored motor function of rats, measured the levels of superoxide dismutase (SOD) and malondialdehyde (MDA) in serum, and also measured the expression of synaptophysin (SYP) and growth associated protein-43 (GAP-43) in the diseased region of cerebral tissue.</p><p><b>RESULTS</b>The motor function scores (11.3 +/- 0.29) and the serum level of SOD (147.1 +/- 12.7) U/ml in acupuncture treatment group were higher than those of model group ( P < 0.05). The serum level of MDA was lower in acupuncture treatment group than that of model group (P < 0.05). The expression of SYP and GAP-43 in the diseased region of cerebral tissue of acupuncture treatment group were higher than those of model group ( P < 0.05) .</p><p><b>CONCLUSION</b>Acupuncture-therapy could improve the motor function of neonate rats with cerebral palsy by decreasing the content of MDA in serum, increasing the contents of SOD in serum, and prolonging the upregulation of SYP and GAP-43 expressions in hmin tissue.</p>


Subject(s)
Animals , Rats , Acupuncture Therapy , Animals, Newborn , Cerebral Palsy , Therapeutics , Disease Models, Animal , GAP-43 Protein , Metabolism , Hypoxia-Ischemia, Brain , Therapeutics , Malondialdehyde , Metabolism , Superoxide Dismutase , Metabolism , Synaptophysin , Metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...